Akebia Therapeutics, Inc.
AKBA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001517022
No open-market purchases or sales by Akebia Therapeutics, Inc. insiders were filed in the last 90 days; 170 institutions reported holding it in 13F filings for Q2 2026, worth $123.2M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Akebia Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 124
- −9 vs. Q4 2021
- Shares held
- 81.2M
- −15.6M (−16.1%) vs. Q4 2021
- Total value
- $58.3M
- −$160.4M (−73.3%) vs. Q4 2021
- New holders
- 17
- 40 more added
- Sold out
- 26
- 43 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AKBA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 170 | $123.2M |
| Q1 2026 | 171 | $141.4M |
| Q4 2025 | 166 | $190.4M |
| Q3 2025 | 177 | $337.7M |
| Q2 2025 | 158 | $394.1M |
| Q1 2025 | 143 | $182.7M |
| Q4 2024 | 121 | $128.9M |
| Q3 2024 | 114 | $78.4M |
| Q2 2024 | 103 | $57.4M |
| Q1 2024 | 114 | $104.3M |
| Q4 2023 | 87 | $72.7M |
| Q3 2023 | 76 | $58.0M |
| Q2 2023 | 79 | $46.0M |
| Q1 2023 | 65 | $29.1M |
| Q4 2022 | 75 | $30.2M |
| Q3 2022 | 90 | $16.5M |
| Q2 2022 | 97 | $20.2M |
| Q1 2022 | 124 | $58.3M |
| Q4 2021 | 133 | $218.7M |
| Q3 2021 | 127 | $283.7M |
| Q2 2021 | 139 | $402.4M |
| Q1 2021 | 145 | $340.3M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Akebia Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 454,997 | $326.0K | 0.00% | −110,900−19.6% | Reduced |
| Connor, Clark & Lunn Investment Management Ltd. | 471,681 | $339.0K | 0.00% | +69,265+17.2% | Added |
| Charles Schwab Investment Management Inc | 476,974 | $343.0K | 0.00% | +33,016+7.4% | Added |
| Susquehanna International Group, LLP | 485,284 | $348.0K | 0.00% | −370,291−43.3% | Reduced |
| Rice Hall James & Associates, LLC | 513,292 | $368.0K | 0.01% | +27,072+5.6% | Added |
| Jane Street Group, LLC | 550,647 | $395.0K | 0.00% | +263,945+92.1% | Added |
| Bank of New York Mellon Corp | 638,883 | $459.0K | 0.00% | +14,038+2.2% | Added |
| Rafferty Asset Management, LLC | 702,647 | $504.0K | 0.00% | −35,428−4.8% | Reduced |
| UBS Group AG | 769,438 | $553.0K | 0.00% | +286,788+59.4% | Added |
| Goldman Sachs Group Inc | 900,967 | $647.0K | 0.00% | −1,246,196−58.0% | Reduced |
| Jacobs Levy Equity Management, Inc | 984,741 | $707.0K | 0.00% | −1,753,159−64.0% | Reduced |
| Morgan Stanley | 995,714 | $714.0K | 0.00% | −200,500−16.8% | Reduced |
| Renaissance Technologies LLC | 1,003,327 | $720.0K | 0.00% | +380,300+61.0% | Added |
| Northern Trust Corp | 1,676,121 | $1.20M | 0.00% | −69,933−4.0% | Reduced |
| Orchard Capital Managment, LLC | 1,762,731 | $1.26M | 0.36% | +169,200+10.6% | Added |
| Federated Hermes, Inc. | 2,030,015 | $1.46M | 0.00% | −4,332−0.2% | Reduced |
| Millennium Management LLC | 2,631,814 | $1.89M | 0.00% | +707,980+36.8% | Added |
| Dimensional Fund Advisors LP | 2,666,861 | $1.92M | 0.00% | +73,020+2.8% | Added |
| Geode Capital Management, LLC | 3,152,758 | $2.26M | 0.00% | −55,231−1.7% | Reduced |
| JPMorgan Chase & Co | 4,258,198 | $3.06M | 0.00% | −174,005−3.9% | Reduced |
| Satter Management Co., L.P. | 4,652,561 | $3.34M | 5.66% | 00.0% | Unchanged |
| State Street Corp | 11,488,224 | $8.25M | 0.00% | −255,237−2.2% | Reduced |
| BlackRock Inc. | 13,961,540 | $10.0M | 0.00% | −162,675−1.2% | Reduced |
| Vanguard Group Inc | 14,402,988 | $10.3M | 0.00% | +1,167,319+8.8% | Added |
| Nantahala Capital Management, LLC | 0 | $0 | 0.00% | −4,918,565−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −4,475,138−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −2,231,966−100.0% | Sold out |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −580,106−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −433,400−100.0% | Sold out |
| Kennedy Capital Management, Inc. | 0 | $0 | 0.00% | −333,841−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −210,000−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −158,507−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −148,321−100.0% | Sold out |
| Virginia Retirement Systems Et Al | 0 | $0 | 0.00% | −111,800−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −97,174−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −80,072−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −76,324−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −54,999−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −43,176−100.0% | Sold out |
| Blair William & Co | 0 | $0 | 0.00% | −16,599−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −13,106−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −12,536−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −10,549−100.0% | Sold out |
| AE Wealth Management LLC | 0 | $0 | 0.00% | −10,300−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −2,004−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −1,630−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −811−100.0% | Sold out |
| Truvestments Capital LLC | 0 | $0 | 0.00% | −900−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −374−100.0% | Sold out |
| PFS Partners, LLC | 0 | $0 | 0.00% | −187−100.0% | Sold out |